PERSIST is an AI-based system designed to predict the risk of relapse in cancer survivors during the five years following initial diagnosis. It uses advanced machine learning techniques applied to electronic health record (EHR) data, such as TNM staging or treatment history.
Currently developed for breast and colon cancer, providing support to healthcare professionals.
Relapse Risk Prediction
The primary application is personalizing the clinical follow-up of oncology patients through individualized relapse risk estimation. Based on EHR data, it provides clinicians with predictions that facilitate decision-making regarding check-ups and care strategies tailored to each patient.
More Personalized Clinical Follow-up:
Improves follow-up management for cancer survivors through early identification of patients with a higher probability of relapse. This enables personalized care, optimizes healthcare resource planning, and moves clinical practice toward more predictive and preventive medicine models.
Request a demo